Shenzhen Neptunus Pharmaceutical

Shenzhen Neptunus Pharmaceutical Group is a prominent Chinese healthcare enterprise specializing in the research, production, and distribution of pharmaceutical products. The company operates across the entire value chain, including drug discovery, large-scale manufacturing, and an extensive retail and wholesale distribution network. Its product portfolio features a wide range of chemical generics, traditional Chinese medicines, and health supplements, with therapeutic focuses on oncology, cardiovascular diseases, and anti-infectives. As a publicly traded entity on the Shenzhen Stock Exchange, Neptunus is recognized for its Neptunus brand, which is one of the most valuable in the Chinese pharmaceutical industry. The company continues to invest in innovative drug development and modernizing traditional medicine to maintain its competitive edge in the domestic market.